Loading...
ROCO
4111
Market cap53mUSD
Jul 09, Last price  
30.35TWD
1D
-0.16%
1Q
3.41%
Jan 2017
36.71%
Name

Chi Sheng Pharma & Biotech Co Ltd

Chart & Performance

D1W1MN
ROCO:4111 chart
P/E
10.53
P/S
1.26
EPS
2.88
Div Yield, %
3.14%
Shrs. gr., 5y
1.10%
Rev. gr., 5y
7.04%
Revenues
1.38b
+18.11%
1,022,956,000979,359,0001,022,298,0001,143,073,0001,060,864,0001,165,437,0001,376,480,000
Net income
164m
+48.49%
72,450,00059,141,00080,751,000154,006,00068,674,000110,633,000164,280,000
CFO
409m
+91.87%
162,958,000143,530,000139,326,000214,856,00074,519,000213,198,000409,054,000
Dividend
Aug 26, 20250.95238 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, and local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.
IPO date
Mar 06, 1999
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT